Diversity of the envelope glycoprotein among human immunodeficiency virus type 1 isolates of clade E, from Asia and Africa

Journal of Virology

Volumn 70, Issue 6, 1996, Pages 3331-3338

  McCutchan, F E ^a,f   Artenstein, A W ^b   Sanders Buell, E ^a   Salminen, M O ^a   Carr, J K ^a   Mascola, J R ^b   Yu, X F ^c   Nelson, K E ^c   Khamboonruang, C ^d   Schmitt, D ^e   Kieny, M P ^e   Mcneil, J G ^b   Burke, D S ^b  

^a HENRY M JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE   (United States)

^b WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d CHIANG MAI UNIVERSITY   (Thailand)

^e TRANSGENE S A   (France)

^f Henry M Jackson Found Res Lab   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

AFRICA; ARTICLE; ASIA; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; PROTEIN POLYMORPHISM; STRAIN DIFFERENCE; VIRUS ENVELOPE; VIRUS STRAIN;

AFRICA; ASIA; BIOLOGY; COMPARATIVE STUDIES; DEVELOPING COUNTRIES; DISEASES; EXAMINATIONS AND DIAGNOSES; GENETICS; HIV INFECTIONS; LABORATORY EXAMINATIONS AND DIAGNOSES; LABORATORY PROCEDURES; PHYSIOLOGY; PROTEINS; RESEARCH METHODOLOGY; RESEARCH REPORT; STUDIES; VACCINES; VIRAL DISEASES;

AFRICA; AMINO ACID SEQUENCE; ANTIGENS, CD4; ASIA; HIV ENVELOPE PROTEIN GP120; HIV ENVELOPE PROTEIN GP41; HIV-1; HUMANS; MOLECULAR SEQUENCE DATA; VIRAL ENVELOPE PROTEINS;

EID: 0029974221     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Ardman, B., M. Kowalski, J. Bristol. W. Haseltine, and J. Sodroski. 1990. Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120. J. Acquired Immune Defic. Syndr. 3:206-214.
2. Artenstein, A. W., J. Coppola, A. E. Brown, J. K. Carr, E. Sanders-Buell, E. Galbarini, J. R. Mascola, T. C. VanCott, P. Schonbrood, F. E. McCutchan, and D. S. Burke. 1995. Multiple introductions of HIV-1 subtype E into the Western Hemisphere. Lancet 346:1197-1198.
3. Artenstein, A. W., T. C. VanCott, J. R. Mascola, J. K. Carr, P. A. Hegerich, J. Gaywee, E. Sanders-Buell, M. L. Robb, D. E. Dayhoff, S. Thitivichianlert, S. Nitayaphan, J. G. McNeil, D. L. Brix, R. A. Michael, D. S. Burke, and F. E. McCutchan. 1995. Dual infection with human immunodeficiency virus type 1 of distinct envelope (env) subtypes in humans. J. Infect. Dis. 171:805-810.
4. Barré-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Ruzious, W. Rozenbaum, and L. Montagnier. 1983. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). Science 220:868-871.
5. Brodine, S. K., J. R. Mascola, P. J. Weiss, S. I. Ito, K. R. Porter, A. W. Artenstein, F. C. Garland, F. E. McCutchan, and D. S. Burke. 1995. Detection of diverse HIV-1 genetic subtypes in the United States. Lancet 346: 1198-1199.
6. Burke, D. S., A. K. Fowler, R. R. Redfleld, S. Dilworth, and C. N. Oster. 1990. Isolation of HIV-1 from the blood of seropositive adults: patient stage of illness and sample innoculum size are major determinants of a positive culture. J. Acquired Immune Defic. Syndr. 3:1159-1167.
7. Burke, D. S., and F. E. McCutchan. 1996. Global distribution of HIV-1 clades. In V. T. DeVita, Jr., S. Hellman, S. A. Rosenberg, M. E. Essex, A. S. Fauci, and J. S. Freeman (ed.), AIDS: etiology, diagnosis, treatment and prevention, 4th ed., in press. J. B. Lippincott Co., Philadelphia.
8. deWolf, F., E. Hogervorst. J. Goudsmit, E.-M. Fenyo, H. Rubsamen-Waigmann, H. Holmes, B. Galvao-Castro, E. Karita, C. Wasi, S. D. K. Sempala, E. Baan, F. Zorgdrager, V. Lukashov, S. Osmanov, C. Kuiken, M. Cornelissen, and the WHO Network for HIV Isolation and Characterization. 1994. Syncitium-inducing and non-syncitium-inducing capacity of human immunodeficiency virus type 1 subtypes other than B: phenotypic and genotypic characteristics. AIDS Res. Hum. Retroviruses 10:1387-1400.
9. Esparza, J., and S. Osmanov. 1993. The development and evaluation of HIV vaccines. Curr. Opin. Infect. Dis. 6:218-229.
10. Fast, P. E., and M. C. Walker. 1993. Human trials of experimental AIDS vaccines. AIDS 7(Suppl. 1):S147-S159.
11. Felsenstein, J. 1981. Evolutionary trees from DNA sequences: a maximum likelihood approach. J. Mol. Evol. 17:368-376.
12. Global AIDS News. 1993. Cambodia faces new threat of AIDS. Newsl. W.H.O. Global Programme AIDS 2:8.
13. Janessens, W., L. Heyndrickx, K. Fransen, J. Motte, M. Peeters, J. N. Nkengasong, P. M. Ndumbe, E. Delaporte, J. L. Perret, C. Atende, P. Piot. and G. van der Groen. 1994. Genetic and phylogenetic analysis of env subtypes G and H in Central Africa. AIDS Res. Hum. Retroviruses 10:877-879.
14. Japour, A. J., S. A. Fiscus, J.-M. Arduino, D. L. Mayers, P. S. Reichelderfer, and D. R. Kuritzes. 1994. Standardized microtiter assay for determination of syncytium-inducing phenotypes of clinical human immunodeficiency virus type 1 isolates. J. Clin. Microbiol. 32:2291-2294.
15. Javaherian, K., A. J. Langlois, C. McDanal, K. L. Roos, L. I. Echler, C. L. Jellis. A. T. Profy, J. R. Rusche, D. P. Bolognesi, and T. J. Matthews. 1989. Principal neutralization domain of the human immunodeficiency virus type 1 envelope protein. Proc. Natl. Acad. Sci. USA 86:6768-6772.
16. Kalish, M. L., A. Baldwin, S. Raktham, C. Wasi, C.-C. Luo, G. Schochetman, T. D. Mastro, N. Young, S. Vanichseni, H. Rubsamen-Waigmann, H. von Briesen, J. I. Mullins, E. Delwart, B. Herring, J. Esparza, W. I. Heyward, and S. Osmanov. 1995. The evolving molecular epidemiology of HIV-1 envelope subtypes in injecting drug users in Bangkok, Thailand: implications for HIV vaccine trials. AIDS 9:851-857.
17. Kinney, T. E., J. N. Weber, J. McClure, P. R. Clapham, M. C. Singhai, M. K. Shriver, and R. A. Weiss. 1988. Neutralising monoclonal antibodies to the AIDS virus. AIDS 2:25-29.
18. Kowalski, M., J. Potz, L. Basiripour, T. Dorfman, W. C. Goh, E. Terwilliger, A. Dayton, C. Rosen, W. Haseltine, and J. Sodroski. 1987. Functional regions of the envelope glycoprotein of human immunodeficiency virus type 1. Science 237:1351-1355.
19. LaRosa, G. J., J. P. Davide, K. Weinhold, J. A. Waterbury, A. T. Profy, J. A. Lewis, A. J. Langlois, G. R. Dreesman, R. N. Boswell, P. Shadduck, C. H. Holley, M. Karplus, D. P. Bolognesi, T. J. Matthews, E. A. Emini, and S. D. Putney. 1990. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249:932-935.
20. Lasky, L. A., G. Nakamura, D. H. Smith, C. Fennie, C. Shimasaki, E. Patzer, P. Herman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 critical for interaction with the CD4 receptor. Cell 47:333-348.
21. Louwagie, J., W. Janssens, J. Mascola, L. Heyndrickx, P. Hegerich, G. van der Groen. F. E. McCutchan, and D. S. Burke. 1995. Genetic diversity of the envelope glycoprotein from human immunodeficiency virus type 1 isolates of African origin. J. Virol. 69:263-271.
22. McCutchan, F. E., P. Hegerich, T. Brennan, P. Phanuphak, P. Preecha, T. Achasa, P. Herman, A. K. Fowler, and D. S. Burke. 1992. Genetic variants of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8:1887-1895.
23. McCutchan, F. E., and G. Myers. The global distribution of HIV-1 genotypes. In J. Mann, D. Tarantola, E. E. Williams, and J. O'Malley (ed.), AIDS in the world, in press. Oxford University Press, London.
24. McKeating, J. A., J. P. Moore, M. Ferguson, H. S. Marsden, S. Graham, J. W. Almond, D. J. Evans, and R. A. Weiss. 1992. Monoclonal antibodies to the C4 region of human immunodeficiency virus type 1 gp120: use in topological analysis of the CD4 binding site. AIDS Res. Hum. Retroviruses 8:451-459.
25. McKeating, J. A., M. Thali, C. Furman, S. Karwowska, M. K. Corny. J. Cordell, S. Zolla-Pazner, J. Sodroski, and R. A. Weiss. 1992. Amino acid residues of the human immunodeficiency virus type 1 gp120 critical for the binding of rat and human neutralizing antibodies that block the gp120-sCD4 interaction. Virology 190:134-142.
26. McNeil, J. G. 1994. Research, development, and evaluation of vaccines for the prevention of HIV-1 in Thailand, p. 21-22. In Proceedings of the International Symposium on Biomedical Research Issues of HIV Infection in Thailand. January 31-February 2, 1994, Bangkok, Thailand. Harvard, Cambridge, Mass.
27. Moore, J. P., F. E. McCutchan, S. W. Poon, J. Mascola, J. Liu, Y. Cao, and D. D. Ho. 1994. Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies. J. Virol. 68:8350-8364.
28. Moore, J. P., A. Trkola, B. Korber, L. J. Boots, J. A. Kessler, F. E. McCutchan, J. Mascola, D. D. Ho, J. Robinson, and A. J. Conley. 1995. A human monoclonal antibody to a complex epitope in the V3 region of gp120 of human immunodeficiency virus type 1 has broad reactivity within and outside clade B. J. Virol. 69:122-130.
29. Murphy, E., B. Korber, M.-C. Georges-Courbot, B. You, A. Pinter, D. Cook, M.-P. Kieny, A. Geogres, C. Mathiot, F. Barré-Sinoussi, and M. Girard. 1993. Diversity of V3 region sequences of human immunodeficiency viruses type 1 from the Central African Republic. AIDS Res. Hum. Retroviruses 9:997-1006.
30. Myers, G., B. Korber, S. Wain-Hobson, K. T. Jeang, L. E. Henderson, and G. N. Pavlakis. 1994. Human retroviruses and AIDS: a compilation and analysis of nucleic acid and amino acid sequences. Theoretical Biology and Biophysics Group, Los Alamos National Laboratory, Los Alamos, N.Mex.
31. Nelson, K. E., D. D. Celentano, S. Suprasert, N. Wright, S. Eiumtrakul, S. Tulvatana, A. Matanasarawoot, P. Akarasewi, S. Kuntolbutra, S. Romyen, N. Siriopana, and C. Theetranont. 1993. Risk factors for HIV infection among young adult men in Northern Thailand. JAMA 270:955-960.
32. Nkengasong, J. N., W. Janssens, L. Heyndrickx, K. Fransen, P. M. Ndumbe, J. Motte, A. Leonaers, M. Ngolle, J. Ayuk, P. Piot, and G. van der Groen. 1994. Genetic subtypes of HIV-1 in Cameroon. AIDS 8:1405-1412.
33. Olshevsky, U., E. Helseth, C. Furman, J. Li, W. Haseltine, and J. Sodroski. 1990. Identification of individual human immunodeficiency virus type 1 gp120 amino acids important for CD4 receptor binding. J. Virol. 64:5701-5707.
34. Ou, C. Y., Y. Takebe, C. C. Luo, M. Kalish. W. Auwanit, C. Bandea, N. de la Torre, H. D. Gayle, N. L. Young, and B. G. Weniger. 1992. Wide distribution of two subtypes of HIV-1 in Thailand. AIDS Res. Hum. Retroviruses 8:1471-1472.
35. Porter, K. R., J. R. Mascola, H. Hupudyo, D. Ewing, T. VanCott, R. I. Anthony, A. Corwin, S. Widido, F. E. McCutchan, D. S. Burke, C. G. Hayes, F. S. Wignall, and R. R. Graham. Genetic, antigenic, and serologic characterization of human immunodeficiency virus type 1 isolates from Indonesia. Submitted for publication.
36. Starcich, B. R., B. H. Hahn, G. M. Shaw, P. D. McNeely, S. Modrow, H. Wolf, E. S. Parks, W. P. Parek, S. F. Josephs, R. C. Gallo, and F. Wong-Staal. 1986. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, and retroviruses of AIDS. Cell 45:637-648.
37. VanCott, T. C., F. R. Bethke, A. W. Artenstein, F. E. McCutchan, J. G. McNeil, J. R. Mascola, R. R. Redfield, and D. L. Birx. 1994 Serotyping international HIV-1 isolates by V3 peptides and whole gp160 proteins using BIAcore. Methods (Orlando) 6:188-198.
38. Weniger, B. G., K. Limpakarnajanarat, K. Ungchusak, S. Thanprasertsuk, K. Choopanya, S. Vanichseni, T. Uneklabh, and P. Thongcharoen. 1991. The epidemiology of HIV infection and AIDS in Thailand. AIDS 5(Suppl. 2): S71-S85.
39. Weniger, B. G., Y. Takebe, C. Y. Ou, and S. Yamazaki. 1994. The molecular epidemiology of HIV in Asia. AIDS 8(Suppl. 2):S13-S28.
40. WHO Network for HIV Isolation and Characterization. 1994. HIV type 1 variation in World Health Organization-sponsored vaccine evaluation sites: genetic screening, sequence analysis, and preliminary biological characterization of selected viral strains. AIDS Res. Hum. Retroviruses 10:1327-1344.
41. WHO Working Group. 1995. The HIV/AIDS pandemic: 1995 overview. Global Programme on AIDS, World Health Organization, Geneva.
42. Yu, X.-F., Z. Wang, C. Beyrer, D. D. Celentano, C. Khamboonruang, E. Allen, and K. Nelson. 1995. Phenotypic and genotypic characterization of human immunodeficiency virus type 1 from patients with AIDS in northern Thailand. J. Virol. 69:4649-4655.
43. Zhang, L. Q., P. Mackenzie, A. Cleland, E. C. Holmes, A. J. Leigh Brown, and P. Simmonds. 1993. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67:3345-3356.
44. Zhu, T., M. Hongmei, N. Wang, D. S. Nam, Y. Cao, R. A. Koup, and D. D. Ho. 1993. Genotypic and phenotypic characterization of HIV-1 in patients with primary infection. Science 261:1179-1181.